Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEP1B | Q16820 | 5/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | MYC | P01106 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.51 |
| ▸ | FNTA | P49354 | 1/20 | 0.50 |
| ▸ | FNTB | P49356 | 1/20 | 0.50 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.50 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.49 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | BCL2 | P10415 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25942433 | 0.86 | MEP1B (0.61) | MEP1BSMN1; SMN2MYCCA1CA2 | |
| SCHEMBL16366609 | 0.85 | MEP1B (0.65) | MEP1BSMN1; SMN2MYCCA1CA2 | |
| SCHEMBL30444148 | 0.85 | MEP1B (0.65) | MEP1BSMN1; SMN2MYCCA1CA2 | |
| SCHEMBL46935 | 0.83 | BCL2 (0.66) | SMN1; SMN2ALDH1A1FOLH1MRGPRX4HIF1A | |
| SCHEMBL30394310 | 0.83 | BCL2 (0.66) | SMN1; SMN2ALDH1A1FOLH1MRGPRX4HIF1A | |
| SCHEMBL6916420 | 0.81 | BCL2 (0.64) | SMN1; SMN2ALDH1A1FOLH1MRGPRX4HIF1A | |
| SCHEMBL6917284 | 0.81 | BCL2 (0.64) | SMN1; SMN2ALDH1A1FOLH1MRGPRX4HIF1A | |
| Ammonia Solution, Strong SCHEMBL22042022 | 0.81 | BCL2 (0.64) | SMN1; SMN2ALDH1A1FOLH1MRGPRX4HIF1A | |
| SCHEMBL6909307 | 0.81 | BCL2 (0.64) | SMN1; SMN2ALDH1A1FOLH1MRGPRX4HIF1A | |
| SCHEMBL6916326 | 0.81 | BCL2 (0.64) | SMN1; SMN2ALDH1A1FOLH1MRGPRX4HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9574189-B2 | Enzymatic encoding methods for efficient synthesis of large libraries | NUEVOLUTION A/S (DK) | 2017-02-21 | — | — | US | disclosed |
| US-9574189-B2 | Enzymatic encoding methods for efficient synthesis of large libraries | NUEVOLUTION A/S (DK) | 2017-02-21 | — | — | US | disclosed |
| US-20090264300-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2009-10-22 | — | — | US | disclosed |
| US-20090264300-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264300-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | RNGTT, DUT, EMG1 | MEP1B 1117/4885SMN1; SMN2 3626/4885MYC 1255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.